Journal article
Hepatic resection for metachronous metastases from ovarian carcinoma
HPB, Vol.8(2), pp.93-96
04/2006
DOI: 10.1080/13651820500472119
PMCID: PMC2131426
PMID: 18333253
Abstract
Recently, several authors have reported that optimal primary cytoreduction of both hepatic and extrahepatic disease is not only feasible but improves survival. However, the role of hepatic resection in combination with secondary cytoreduction for epithelial ovarian cancer is unclear. Patients with recurrent ovarian cancer and metachronous intrahepatic metastases are often evaluated by a multidisciplinary team at the Mayo Clinic comprising pelvic and hepatobiliary surgeons for consideration of cytoreductive surgery. The purpose of this report is to update the outcome of cytoreductive surgery including hepatic resection for patients with metastatic ovarian carcinoma.
Details
- Title: Subtitle
- Hepatic resection for metachronous metastases from ovarian carcinoma
- Creators
- Jesus Gonzalez Bosquet - Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN, USAMelissa A Merideth - Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN, USAKarl C Podratz - Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN, USADavid M Nagorney - Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN, USA
- Resource Type
- Journal article
- Publication Details
- HPB, Vol.8(2), pp.93-96
- Publisher
- Elsevier Ltd
- DOI
- 10.1080/13651820500472119
- PMID
- 18333253
- PMCID
- PMC2131426
- ISSN
- 1365-182X
- eISSN
- 1477-2574
- Language
- English
- Date published
- 04/2006
- Academic Unit
- Obstetrics and Gynecology
- Record Identifier
- 9983931813702771
Metrics
30 Record Views